Plasma Pharmacokinetic Determination of Canagliflozin and Its Metabolites in a Type 2 Diabetic Rat Model by UPLC-MS/MS. [electronic resource]
- Molecules (Basel, Switzerland) May 2018
Publication Type: Journal Article
1420-3049
10.3390/molecules23051229 doi
Administration, Oral Animals Canagliflozin--administration & dosage Chromatography, High Pressure Liquid--methods Diabetes Mellitus, Experimental--blood Diabetes Mellitus, Type 2--blood Humans Hypoglycemic Agents--administration & dosage Limit of Detection Male Molecular Structure Rats Rats, Sprague-Dawley Streptozocin Tandem Mass Spectrometry--methods